News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

“It has been a great privilege to be part of a project which empowers women to prioritise their health"

Following the success of 2022’s event, the Oncology & Precision Medicine Conference once again took place over two days to facilitate a more in-depth programme, with 149 delegates meeting...

World-leading research into diseases such as prostate cancer and mitochondrial disease at Northumbria University.

For the first time in 2022, the Oncology & Precision Medicine Conferences were a two-day event with 120 delegates coming together to discuss the current oncology landscape and the future of ...

An academic from Teesside University has been awarded £100,000 to fund essential brain cancer research, which aims to advance diagnosis and treatments.

Sygnature Discovery is a leading independent provider of integrated drug discovery and pre-clinical resource and expertise.

Yourgene (AIM: YGEN), the international molecular diagnostics group, announces its oncology product, Elucigene DPYD test, is now being used in Wales to routinely screen all cancer patients p...

Recent cell and gene therapy product approvals have allowed the pharmaceutical industry to start a new age of innovation regarding cancer treatment, moving away from the more homogeneous the...

Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, is further strengthening its oncology and immuno-oncology capabilities with the acquis...

With direct-to-consumer genetic tests becoming more popular and governments looking to collect and utilise genetic data in clinical and research settings, it appears the amount of genetic da...

Repositive today announced that its Cancer Models Directory, containing over 5,300 preclinical cancer models, is available on Science Exchange, the widely used technology platform for outsou...

Repositive announces the appointment of Slaven Stekovic as Head of Strategic Growth, along with leading commercial experts (Mariana Vaschetto and Francesca Crawford) to its advisory board.

Sign up to our Newsletter

Subscribe

* indicates required

Our Valued Sponsors & Partners